917 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
4 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
5 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
6 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
7 Not yet recruiting Clinical Trial of Lurbinectedin (PM01183) Plus Doxorubicin (DOX) Versus Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line
Condition: Small-cell Lung Cancer
Interventions: Drug: Lurbinectedin (PM01183);   Drug: Doxorubicin;   Drug: Topotecan
8 Not yet recruiting Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery
Conditions: Metastatic Neoplasm;   Recurrent Neoplasm;   Recurrent Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer;   Unresectable Malignant Neoplasm
Interventions: Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Targeted Therapy
9 Not yet recruiting Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC)
Condition: Metastatic Squamous Non-small Cell Lung Cancer
Interventions: Drug: Pembrolizumab;   Drug: Placebo
10 Not yet recruiting Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor
Conditions: Non-small Cell Lung Cancer;   Gastric Cancer;   Hepatocellular Carcinoma;   Colorectal Cancer
Intervention: Biological: natural killer T cell
11 Not yet recruiting SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung Cancer
Conditions: Carcinoma, Non-Small-Cell-Lung;   Non-Small Cell Lung Cancer;   Nonsmall Cell Lung Cancer
Interventions: Behavioral: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30;   Behavioral: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire LC-13;   Behavioral: Modified Medical Research Council;   Behavioral: EQ-5D;   Behavioral: Center for Epidemiological Studies Depression Scale;   Behavioral: Medical Outcomes Study Social Support Survey
12 Recruiting Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care
Condition: Non-Small Cell Lung Carcinoma (NSCLC)
Intervention: Other: Survey
13 Recruiting IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases
Condition: Non-Small Cell Lung Carcinoma
Interventions: Radiation: IMRT and erlotinib;   Radiation: WBRT
14 Recruiting Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPM
Conditions: Non Small Cell Lung Cancer (NSCLC);   Malignant Pleural Mesothelioma (MPM)
Intervention: Drug: Vinorelbine
15 Recruiting Genomic Landscape of Ceritinib
Conditions: Carcinoma, Non-Small-Cell Lung;   Non-small Lung Cancer;   Non-Small Cell Lung Cancer
16 Not yet recruiting Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Drug: pembrolizumab, paclitaxel
17 Not yet recruiting Association Between Circulating Immune Cells and the Tumor Immune Contexture in Resectable Non-small Cell Lung Cancer
Condition: Resectable Non-small Lung Cancer
Interventions: Procedure: blood drawn;   Procedure: surgical resection of cancer
18 Available Rociletinib (CO-1686) USA Expanded Access Program
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Rociletinib
19 Not yet recruiting Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: CC-486;   Drug: Pembrolizumab;   Drug: Placebo
20 Not yet recruiting Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: MGCD265

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years